Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Janagliflozin Monotherapy in Chinese Patients with T2DM
NCT03811548Phase 3Unknown
- Sponsor
- Sihuan Pharmaceutical
- Start
- May 2019
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of janagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Sihuan Pharmaceutical. Status: unknown.
02
Drugs
janagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03811548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03811548.